NASDAQ:EYES

Second Sight Medical Products Earning Date

USA |NASDAQ |USD

EYES Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Dec 31, 2021 (est) Sep 30, 2021 - $-0.08 $-0.06
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Dec 31, 2021 (est) Sep 30, 2021 - $0.00 $0.00

Second Sight Medical Products's next estimated earnings date (based on same quarter last year's date) is Dec 31, 2021 for the fiscal quarter ending Sep 30, 2021.

EYES Earnings Date & History Chart

EYES Earnings & Revenue Forecast

EYES Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 0 $0.00 $0.00 $0.00

EYES Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-1.40 $-1.40 $-1.40

EYES Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 1 $240.00K $240.00K $240.00K

EYES Earnings Date & Revenue History

EYES Earnings History

|
Show More
Show More

EYES Revenue History

|
Show More
Show More

Second Sight Medical Products Next Earnings Date & Report

EYES Aug 2021 (FQ) Earnings Date & Report Preview

EYES's next estimated earnings date (based on same quarter last year's report date) is Dec 31, 2021 for the fiscal quarter ending Sep 30, 2021.

Second Sight Medical Products Previous Earnings Dates & Reports

EYES Previous Earnings Date & Report Recap: Jun 2021 (FQ)

Second Sight Medical Products's previous earnings date was Aug 17, 2021 for its fiscal quarter ended Jun 30, 2021.

EYES's earnings per share (EPS) was $-0.08.

The EPS was higher than the previous fiscal quarter (Mar 2021) by 0.00%, and lower than the same period a year before (Jun 2020) by 15.44%.

Revenues were $0.00.

The company reported a net income of $-2.29M.

Free cash flow for the quarter was $-4.18M , compared to $-778.00K last quarter and $-5.24M a year before.

EYES ended the quarter with $324.00K in total debt, a decrease of -87.37% compared to the previous quarter, and an increase of 205.66% compared to the same quarter a year before.

EYES Previous Earnings Date & Report Recap: Dec 2020 (FY)

Second Sight Medical Products's previous annual earnings date was Mar 31, 2021 for its fiscal year ended Dec 31, 2020.

EYES's earnings per share (EPS) was $-0.82, missing the consensus analysts forecast of $0.00 by % , and higher than the previous year's EPS (Dec 2019) by -59.01%.

Revenues were $1.00K.

The company reported a net income of $-14.88M.

Second Sight Medical Products reported a free cash flow of $-17.15M for its fiscal year, compared to $-28.12M a year ago.

The company ended the fiscal year with $2.20M in total debt, a decrease of -15.45% compared to the previous year.